Bulevirtide monotherapy in patients with chronic HDV: Efficacy and safety results through week 96 from a phase III randomized trial von Wedemeyer, Heiner, Aleman, Soo, Brunetto, Maurizia, Blank, Antje, Andreone, Pietro, Bogomolov, Pavel, Chulanov, Vladimir, Mamonova, Nina, Geyvandova, Natalia, Morozov, Viacheslav, Sagalova, Olga, Stepanova, Tatyana, Berger, Annemarie, Ciesek, Sandra, Manuilov, Dmitry, Mercier, Renee-Claude, Da, Ben L., Chee, Grace M., Li, Mingyang, Flaherty, John F., Lau, Audrey H., Osinusi, Anu, Schulze zur Wiesch, Julian, Cornberg, Markus, Zeuzem, Stefan, Lampertico, Pietro

Volltext

Interferon Free Hepatitis C Treatment Regimens: The Beginning of Another Era von Poordad, Fred, Chee, Grace M.

Volltext

Viral Resistance in Hepatitis B: Prevalence and Management von Poordad, Fred, Chee, Grace M.

Volltext

FRI-383 Unique characteristics and risk of liver-related events among individuals with hepatitis D virus infection with and without concurrent hepatitis C virus infection: a United... von Telep, Laura, Wyles, David, Chee, Grace M., Chokkalingam, Anand, Singer, Amanda, Kushner, Tatyana

Volltext

S1273 The Natural History of Liver Fibrosis Progression Rate in Hepatitis C Infection von Yamini, David, Basseri, Benjamin, Arakelyan, Anush, Enayati, Pedram, Tran, Tram T, Chee, Grace M, Poordad, Fred

Volltext

FRI-407 Screening rates, prevalence, and natural history of hepatitis B/ delta virus co-infection vs. hepatitis B mono-infection: data from a large US integrated healthcare system von Saxena, Varun, Tucker, Lue-Yen, Li, Xiaoran, Chai, Krisna, Seo, Suk, Mukhtar, Nizar, Chee, Grace M., Kwon, Kyung Min, Balasubramanian, Sreepriya, Macdonald, Brock, Schmittdiel, Julie

Volltext

S2080 Platelet Counts Are Predictive of Fibrosis Stage Across Most, But Not All, Liver Disease Etiologies von Parker, Elaine W, Tran, Tram T, Jensen, Chris, Mirocha, James M, Enayati, Pedram, Basseri, Benjamin, Rakoski, Mina O, Chee, Grace M, Poordad, F. Fred

Volltext

M1772 Demographics, Co-Morbidities, Social Behaviors and Laboratory Data: Which Factors Impact/Predict Fibrosis in the Natural History of Hepatitis C? von Basseri, Benjamin, Enayati, Pedram, Yamini, David, Parker, Elaine W, Tran, Tram T, Park, Janice, Ain, Dani, Chee, Grace M, Poordad, F. Fred

Volltext

S2078 Tobacco Has a Negative Impact On the Hepatitis C Patient von Basseri, Benjamin, Yamini, David, Enayati, Pedram, Parker, Elaine W, Tran, Tram T, Shi, Vivian Y, Jensen, Chris, Chee, Grace M, Poordad, F. Fred

Volltext

SAT-373 Intrahepatic sodium taurocholate co-transporting polypeptide gene transcript and membrane-localized protein expression changes in chronic hepatitis D patients following 48... von Nieves, Wildaliz, Pan, David, Aggarwal, Abhishek, Zaboli, Shiva, Moon, Christina, Diehl, Lauri, Ni, Liyun, Manhas, Savrina, Mo, Hongmei, Allweiss, Lena, Manuilov, Dmitry, Chee, Grace M., Mercier, Renee-Claude, Wallin, Jeffrey, Dandri-Petersen, Maura

Volltext

WED-392 Improvement in liver histology is observed in most patients with chronic hepatitis delta after 48weeks of bulevirtide monotherapy von Lampertico, Pietro, Aleman, Soo, Bogomolov, Pavel, Stepanova, Tatyana, Cornberg, Markus, Ciesek, Sandra, Berger, Annemarie, Manuilov, Dmitry, Li, Mingyang, Lau, Audrey H., Da, Ben L., Chee, Grace M., Brunetto, Maurizia, Zeuzem, Stefan, Wedemeyer, Heiner

Volltext

GS-002 48-week off-therapy efficacy and safety of bulevirtide in combination with pegylated interferon alfa-2a in patients with chronic hepatitis delta: final results from the phas... von Asselah, Tarik, Chulanov, Vladimir, Lampertico, Pietro, Wedemeyer, Heiner, Streinu-Cercel, Adrian, Pantea, Victor, Lazar, Stefan, Gherlan, George Sebastian, Bogomolov, Pavel, Stepanova, Tatyana, Morozov, Viacheslav, Syutkin, Vladimir, Sagalova, Olga, Manuilov, Dmitry, Mercier, Renee-Claude, Ye, Lei, Chee, Grace M., Da, Ben L., Lau, Audrey H., Osinusi, Anu, Bourliere, Marc, Ratziu, Vlad, Pol, Stanislas, Hilleret, Marie-Noëlle, Zoulim, Fabien

Volltext

FRI-371 Undetectable HDV RNA at 24 weeks of treatment with combination therapy is an important predictor of maintained response off-therapy von Zoulim, Fabien, Chulanov, Vladimir, Lampertico, Pietro, Wedemeyer, Heiner, Streinu-Cercel, Adrian, Pantea, Victor, Lazar, Stefan, Gherlan, George Sebastian, Bogomolov, Pavel, Stepanova, Tatyana, Morozov, Viacheslav, Syutkin, Vladimir, Sagalova, Olga, Manuilov, Dmitry, Mercier, Renee-Claude, Ye, Lei, Chee, Grace M., Da, Ben L., Lau, Audrey H., Osinusi, Anu, Bourliere, Marc, Ratziu, Vlad, Pol, Stanislas, Hilleret, Marie-Noëlle, Asselah, Tarik

Volltext

TOP-400 Impact of bulevirtide given with or without nucleos (t)ide analogues on 48-week virologic outcomes in patients with chronic hepatitis delta virus infection von Lampertico, Pietro, Brunetto, Maurizia, Buti, Maria, Aleman, Soo, Bogomolov, Pavel, Chulanov, Vladimir, Mamonova, Nina, Morozov, Viacheslav, Sagalova, Olga, Stepanova, Tatyana, Flaherty, John F., Li, Mingyang, Manuilov, Dmitry, Da, Ben L., Mercier, Renee-Claude, Chee, Grace M., Cornberg, Markus, Wedemeyer, Heiner, Asselah, Tarik

Volltext

WED-395 Undetectable hepatitis delta virus RNA at the end of treatment with bulevirtide and pegylated interferon alpha-2a is an important predictor of 48 weeks sustained virologic... von Zoulim, Fabien, Asselah, Tarik, Chulanov, Vladimir, Streinu-Cercel, Adrian, Gherlan, George Sebastian, Bogomolov, Pavel, Stepanova, Tatyana, Morozov, Viacheslav, Sagalova, Olga, Mercier, Renee-Claude, Ye, Lei, Manuilov, Dmitry, Lau, Audrey H., Chee, Grace M., Da, Ben L., Bourliere, Marc, Wedemeyer, Heiner, Lampertico, Pietro

Volltext

LBP-029 Efficacy and safety of 144 weeks of bulevirtide 2 mg or 10 mg monotherapy from the ongoing phase 3 study, MYR301 von Lampertico, Pietro, Aleman, Soo, Brunetto, Maurizia, Blank, Antje, Andreone, Pietro, Bogomolov, Pavel, Chulanov, Vladimir, Mamonova, Nina, Geyvandova, Natalia, Morozov, Viacheslav, Sagalova, Olga, Stepanova, Tatyana, Chee, Grace M., Manuilov, Dmitry, Li, Mingyang, Tseng, Steve, Lau, Audrey, Osinusi, Anu, zur Wiesch, Julian Schulze, Cornberg, Markus, Zeuzem, Stefan, Wedemeyer, Heiner

Volltext

Bulevirtide Monotherapy Is Safe and Well Tolerated in Chronic Hepatitis Delta: An Integrated Safety Analysis of Bulevirtide Clinical Trials at Week 48 von Asselah, Tarik, Lampertico, Pietro, Aleman, Soo, Bourlière, Marc, Streinu-Cercel, Adrian, Bogomolov, Pavel, Morozov, Viacheslav, Stepanova, Tatiana, Lazar, Stefan, Manuilov, Dmitry, Mercier, Renee-Claude, Tseng, Steve, Ye, Lei, Flaherty, John F, Osinusi, Anu, Da, Ben L, Chee, Grace M, Lau, Audrey H, Brunetto, Maurizia R, Wedemeyer, Heiner

Volltext

Bulevirtide monotherapy in patients with chronic HDV: Efficacy and safety results through week 96 from a phase 3 randomized trial von Wedemeyer, Heiner, Aleman, Soo, Brunetto, Maurizia, Blank, Antje, Andreone, Pietro, Bogomolov, Pavel, Chulanov, Vladimir, Mamonova, Nina, Geyvandova, Natalia, Morozov, Viacheslav, Sagalova, Olga, Stepanova, Tatyana, Berger, Annemarie, Ciesek, Sandra, Manuilov, Dmitry, Mercier, Renee-Claude, Da, Ben L, Chee, Grace M, Li, Mingyang, Flaherty, John F, Lau, Audrey H, Osinusi, Anu, Schulze Zur Wiesch, Julian, Cornberg, Markus, Zeuzem, Stefan, Lampertico, Pietro

Volltext

The Singapore National Precision Medicine Strategy von Wong, Eleanor, Bertin, Nicolas, Hebrard, Maxime, Tirado-Magallanes, Roberto, Bellis, Claire, Lim, Weng Khong, Chua, Chee Yong, Tong, Philomena Mei Lin, Chua, Raymond, Mak, Kenneth, Lim, Tit Meng, Cheong, Wei Yang, Thien, Kwee Eng, Goh, Khean Teik, Chai, Jin-Fang, Lee, Jimmy, Sung, Joseph Jao-Yiu, Wong, Tien Yin, Chin, Calvin Woon Loong, Gluckman, Peter D., Goh, Liuh Ling, Ban, Kenneth Hon Kim, Tan, Tin Wee, Sim, Xueling, Cheng, Ching-Yu, Davila, Sonia, Karnani, Neerja, Leong, Khai Pang, Liu, Jianjun, Prabhakar, Shyam, Maurer-Stroh, Sebastian, Verma, Chandra Shekhar, Krishnaswamy, Pavitra, Goh, Rick Siow Mong, Chia, Irenaeus, Ho, Clarissa, Low, Doreen, Virabhak, Suchin, Yong, Jacklyn, Zheng, Weiling, Seow, Shih Wee, Seck, Yee Kwang, Koh, Mingshi, Chambers, John C., Tai, E. Shyong, Tan, Patrick

Volltext

Outbreak of Zika virus infection in Singapore: an epidemiological, entomological, virological, and clinical analysis von Ho, Zheng Jie Marc, Hapuarachchi, Hapuarachchige Chanditha, Barkham, Timothy, Chow, Angela, Ng, Lee Ching, Lee, Jian Ming Vernon, Leo, Yee Sin, Prem, Kiesha, Lim, Yue Hui Georgina, de Sessions, Paola F, Rabaa, Maia A, Chong, Chee Seng, Tan, Cheong Huat, Rajarethinam, Jayanthi, Tan, Junhao, Anderson, Danielle E, Ong, Xinmei, Cook, Alex R, Chong, Chia Yin, Hsu, Li Yang, Yap, Grace, Lai, Yee Ling, Chawla, Tanu, Pan, Louise, Sim, Shuzhen, Chen, I-Cheng Mark, Thoon, Koh Cheng, Yung, Chee Fu, Li, Jia Hui, Ng, Hee Ling Deborah, Nandar, Khine, Ooi, Peng Lim, Lin, Raymond Tzer Pin, Aw, Pauline, Uehara, Anna, Pratim De, Partha, Soon, Wendy, Hibberd, Martin Lloyd, Ng, Huck Hui, Maurer-Stroh, Sebastian, Sessions, October M

Volltext